Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms

Kaitlyn M. Yim, April W. Armstrong

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

Psoriasis and psoriatic arthritis are associated with a significantly increased risk of cardiovascular risk factors and major adverse cardiovascular events (MACE). Active research is ongoing to elucidate this relationship between psoriatic diseases and cardiovascular comorbidities, as well as their shared pathogenic mechanisms. This review focuses on (1) the epidemiologic association between psoriasis and cardiovascular risk factors, (2) the epidemiologic association between psoriasis and MACE, (3) the epidemiologic association between psoriatic arthritis, cardiovascular risk factors, and MACE, and (4) proposed mechanisms for the contribution of psoriatic diseases to cardiovascular diseases. The proposed mechanisms for shared pathogenesis between psoriatic diseases and cardiovascular diseases are inflammation, insulin resistance, dyslipidemia, angiogenesis, oxidative stress, and endothelial dysfunction. There is complex interplay and overlap among these mechanisms and their contributions to shared pathogenesis. Future translational research is necessary to elucidate the link between psoriatic diseases and cardiovascular diseases. Such findings may be applied clinically to improve the lives of psoriasis patients.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalRheumatology International
DOIs
StateAccepted/In press - May 24 2016
Externally publishedYes

    Fingerprint

Keywords

  • Cardiovascular comorbidities
  • Comorbidities
  • Inflammation
  • Mechanisms
  • Psoriasis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this